The aim of the study: The aim of the study was to determine the influence of demographic factors, symptoms of cervical dystonia and the effect of the botulinum toxin dosage on therapeutic response. Subjects and Methods: 41 people in outpatient treatment with cervical dystonia were treated at KBC Osijek (Clinical Centre) Clinic for Neurology. A questionnaire constructed for the purpose of this study was used to include the following data: age, gender, height, weight, duration of cervical dystonia symptoms, botulinum toxin dosage, time (days) passed from application to first therapeutic effect, duration of applied botulinum toxins (months) and side effects. The Tsui scales were used to evaluate the severity of motor symptoms and the PGIC Scale was used for subjective assessment of symptoms improvement. Results: The research has shown that pain is more present in patients with laterocolis, sagittal shift and mixed type of dystonia. Significant negative correlation was found between the botulinum toxin dosage and subjective patient-assessed motor response. The most common side effects after the administration of botulinum toxins are dysphagia in 6 (15%), muscular weakness in two (5%) and the rest in 5 (12%) subjects. The type of cervical dystonia does not affect the PGIC-rated motor response, the latency of the therapeutic response after the first application and the length of the therapeutic response. Conclusion: The study has shown that patients who received a lower dosage of botulinum toxins had a better subjective evaluation of the therapeutic response to the motor symptoms. We haven't found correlations of age, gender, severity of motor symptoms with therapeutic response. For a favourable therapeutic response, the most important factor is a good estimate of the muscle group to be treated, the approachability of these muscles for the application and the good application skills of the one who applies it.